Position in AKTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$536,700
New position
Shares Held
30,000
first reported quarter
Ownership
0.054%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026READYSTATE ASSET MANAGEMENT LP holds $117,126,076 across 18 Biotechnology names. AKTS ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLNO |
Soleno Therapeutics Inc
|
952,165 | $31,878,484 | |
| 2 | IMNM |
Immunome Inc.
|
1,301,862 | $28,471,721 | |
| 3 | ABVX |
Abivax S.A.
|
202,022 | $22,495,149 | |
| 4 | QURE |
uniQure N.V.
|
504,702 | $8,251,877 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
883,621 | $7,484,269 | |
| 6 | BHVN |
Biohaven Ltd.
|
388,193 | $3,284,112 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
31,847 | $3,097,120 | |
| 8 | MLTX |
MoonLake Immunotherapeutics
|
144,238 | $2,688,596 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $536,700 | 30,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||